Clinical Trials in Nashville

Showing 19161-19180 of 20,298 trials

TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

NCT00077883

The purpose of this trial is to study the efficacy and safety of the combination of TLK286 with cisplatin as first-line therapy for patients with locally advanced or metastatic non-small cell lung cancer.

Non-small Cell Lung Cancer

Telik50 participantsStarted Feb 2004

Baltimore, Maryland, United States • Nashville, Tennessee, United States • Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer

NCT00057720

The purpose of this study is to demonstrate superiority in survival in favor of TLK286 as compared to active control therapy with Doxil/Caelyx or Hycamtin in the intent-to-treat (ITT) populations.

Ovarian Neoplasms

Telik440 participantsStarted Jun 2003

Little Rock, Arkansas, United States • Little Rock, Arkansas, United States • Baldwin Park, California, United States +317 more locations

TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer

Find Trials by Condition in Nashville

A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia

A Clinical Study to Assess the Safety of a New Influenza Vaccine

Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa

Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer

Phase 2 Study of TLK286 in Metastatic Breast Cancer

A Study for Patients With Type 2 Diabetes Mellitus

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Evaluation of Diagnostic HIV Ag/Ab Combo Assay

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas

Oral Vitamin K for Warfarin Associated Coagulopathy

A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI

HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth